v3.26.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities    
Net income $ 7,396 $ 2,759
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:    
Depreciation and amortization 509 463
Change in deferred income taxes (1,478) (392)
Stock-based compensation expense 161 154
Acquired in-process research and development 584 1,572
Other changes in operating assets and liabilities, net of acquisitions and divestitures (1,664) (3,364)
Other operating activities, net (175) 474
Net Cash Provided by Operating Activities 5,333 1,666
Cash Flows from Investing Activities    
Purchases of property and equipment (2,326) (1,510)
Purchases of noncurrent investments (297) (197)
Purchases of in-process research and development (204) (1,757)
Cash paid for acquisitions, net of cash acquired (1,058) 0
Other investing activities, net (31) 111
Net Cash Used for Investing Activities (3,916) (3,353)
Cash Flows from Financing Activities    
Dividends paid (1,548) (1,346)
Net change in short-term borrowings 1,775 (1,849)
Proceeds from issuance of long-term debt 0 6,461
Repayments of long-term debt (750) 0
Purchases of common stock (2,356) (1,200)
Other financing activities, net (591) (686)
Net Cash (Used for) Provided by Financing Activities (3,470) 1,380
Effect of exchange rate changes on cash and cash equivalents 67 132
Net decrease in cash and cash equivalents (1,986) (175)
Cash and cash equivalents at January 1 7,268 3,268
Cash and Cash Equivalents at March 31 $ 5,282 $ 3,093